Long‐term follow‐up of intradetrusor botulinum toxin utilisation: A comparison of patients with multiple sclerosis and idiopathic overactive bladder
Patients with MS and neurogenic OAB have a good therapeutic effect from intradetrusor BoNT that is sustained over at least 10 cycles with significant reduction in the duration of action with subsequent cycles.
Authors
- Alvaro Bazo (ORCID: https://orcid.org/0000-0003-2125-0319)
- Helen E. O’Connell (ORCID: https://orcid.org/0000-0001-8565-1301)
- Joshua Kealey (ORCID: https://orcid.org/0000-0001-7387-5084)
- Johan Gani (ORCID: https://orcid.org/0000-0002-1666-0148)
- Henry H. Yao (ORCID: https://orcid.org/0000-0003-1955-6992)
- William Chui (ORCID: https://orcid.org/0000-0002-2471-4126)
- Richard Parkinson (ORCID: https://orcid.org/0000-0002-5600-6992)
- Garson Chan (ORCID: https://orcid.org/0000-0002-2241-6635)
Institutions
- Nottingham University Hospitals NHS Trust (GB)
- The University of Melbourne (AU)
- Eastern Health (AU)
- Western Health (AU)
- Monash University (AU)
Publication Details
- Journal
- BJUI Compass
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1002/bco2.479
- Citations
- 1
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.54
Funders
- University of Melbourne